证券记录 · 已归档季度
BIIB
Biogen Inc. · Healthcare · Drug Manufacturers - General
24被追踪持有人
+1Δ持有人
81.72M持有股份
$11.44B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +4.3% ·
股份流向 -0.4% ·
净新建仓位 0.0%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 75.75K | $11.04M | n/a | −3 |
| Q2 2026 | 159 | 0 | 117.81M | $25.44B | +6 | −7 |
| Q1 2026 | 163 | -1 | 110.78M | $20.30B | +4 | −6 |
| Q4 2025 | 163 | 0 | 123.15M | $21.67B | +2 | −1 |
| Q3 2025 | 24 | +1 | 81.72M | $11.44B | +1 | −1 |
| Q2 2025 | 21 | 0 | 78.50M | $9.86B | n/a | n/a |
| Q1 2025 | 18 | +2 | 41.87M | $5.73B | +3 | −1 |
| Q4 2024 | 16 | -1 | 41.64M | $6.37B | n/a | −1 |
| Q3 2024 | 16 | +2 | 32.39M | $6.28B | +2 | n/a |
| Q2 2024 | 14 | n/a | 30.72M | $7.12B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 17.29M | 0.0% | $2.42B | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 2 | PRIMECAP Management ✦ | 14.95M | -5.4% | $2.09B | 1.6% | ▼ Trim | 6 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 14.76M | +8.9% | $2.07B | 0.0% | ▲ Add | 2 | SEC ↗ ×21 |
| 4 | State Street Global Advisors ✦ (被动) | 7.32M | -2.0% | $1.03B | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.25M | -11.5% | $594.85M | 0.1% | ▼ Trim | 6 | SEC ↗ ×5 |
| 6 | Geode Capital Management ✦ (被动) | 4.07M | +3.8% | $567.74M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Point72 Asset Management ✦ | 3.87M | +1.1% | $542.52M | 1.3% | ▲ Add | 3 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 2.54M | n/a | $355.34M | 0.0% | n/c | 1 | SEC ↗ ×30 |
| 9 | Morgan Stanley ✦ | 2.25M | n/a | $315.40M | 0.0% | n/c | 1 | SEC ↗ ×19 |
| 10 | AQR Capital Management ✦ | 1.78M | +30.7% | $248.81M | 0.2% | ▲ Add | 6 | SEC ↗ ×6 |
| 11 | Fidelity (FMR) ✦ | 1.29M | -23.1% | $180.39M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 12 | Millennium Management ✦ | 1.11M | +64.5% | $155.66M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 1.06M | n/a | $148.99M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 14 | T. Rowe Price ✦ | 965.46K | +15.8% | $135.24M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 15 | Renaissance Technologies ✦ | 964.41K | -7.7% | $135.09M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 16 | Marshall Wace ✦ | 887.66K | +434.9% | $124.34M | 0.1% | ▲ Add | 5 | SEC ↗ ×3 |
| 17 | D. E. Shaw & Co. ✦ | 477.92K | -65.0% | $66.95M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 18 | Arrowstreet Capital ✦ | 380.79K | -39.0% | $53.34M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 372.73K | -38.8% | $52.21M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 332.13K | +34.0% | $46.53M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 277.29K | -4.1% | $38.84M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 270.50K | +65.5% | $37.89M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 205.23K | -59.6% | $28.75M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | Bridgewater Associates ✦ | 39.98K | 新增 | $5.60M | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Bridgewater Associates | $5.60M | 0.0% |
已清仓
| Norges Bank | $284.36M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 995 持有人, 132.27M 股份, $23.30B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Aug 06
SC 13G/A: FMR LLC
Jun 05
SC 13G/A: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据